Fig. 1From: Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaiseChanges in carnitine values. Compared with Pre-IC, FC was significantly decreased on Post-IC21. However, absolute deficiency did not developBack to article page